MSM licence revoked

- Last updated on GMT

Related tags: Msm, License

A licence granting Carolwood Corporation the right to produce
products containing methyl-sulfonyl-methane (MSM) has been revoked
by the product's creator MSM Investments.

A licence granting Carolwood Corporation the right to produce products containing methyl-sulfonyl-methane (MSM) has been revoked by the product's creator MSM Investments.

MSM is used in a number of supplements designed to treat arthritis and other inflammatory conditions, and was created by Robert Herschler, the head of MSM Investments.

Herschler said that he had terminated the agreement with Carolwood on 15 May 2002 after Carolwood failed to pay royalties and therefore breached the terms of the licensing agreement signed in December 1999.

MSM Investments sued Carolwood in April 2001 in a federal court in Oregon for breach of contract and other claims. That lawsuit is still pending, Herschler said.

Carolwood was not the sole licensee for MSM, however. Cardinal Nutrition of Vancouver, Washington, and Chemiplus, located in Japan, will still be able to produce and market MSM products.

Related news

Related products

show more

Taking the healthy way, follow The Life Guardian™.

Taking the healthy way, follow The Life Guardian™.

Indena: botanical ingredients for the Health Food industry | 11-Feb-2020 | Technical / White Paper

Meriva® – curcumin Phytosome offers the complete power of all 3 major curcuminoids and its optimized bioabsorpion thanks to Phytosome Indena’s delivery...

NEXT GENERATION CURCUMIN

NEXT GENERATION CURCUMIN

SABINSA | 27-Jan-2020 | Data Sheet

Sabinsa’s patented, colorless, Curcumin C3 Reduct® is 250 times more effective than curcumin in activating AMP Kinase (Intracellular Fuel Gauge). This...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars